US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Clearmind Medicine, Inc.

1.03

0.0000

Post-market: 1.02-0.0099-0.96%19:41 EDT

Volume:51.12K

Turnover:52.71K

Market Cap:5.29M

PE:-0.91

High:1.08

Open:1.03

Low:1.02

Close:1.03

Loading ...

Overview Company News Filings

Psychedelic: Clearmind completes site initiation for CMND-100 trial

Clearmind Medicine completes initiation at TASMC for Phase I/IIa trial

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

Clearmind Medicine Inc. Expands Clinical Trial for CMND-100 in Alcohol Use Disorder with New Site at Johns Hopkins University

Clearmind Medicine Gets Approval for Alcohol Use Disorder Clinical Trial in Israel

MT Newswires Live

Clearmind Medicine announces IRB approval for Phase 1/2a trial for AUD

Clearmind Medicine Inc. Doses First Participant in Groundbreaking Clinical Trial for Alcohol Use Disorder Treatment

Clearmind Medicine announces first participant ever dosed with CMND-100

Clearmind Adds New Site to Trial for Experimental Alcohol Use Disorder Drug

MT Newswires Live

Clearmind Medicine expands global clinical trial targeting AUD market

BRIEF-Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

Clearmind Medicine Expands Alcohol Use Disorder Clinical Trial with Addition of Tel Aviv Sourasky Medical Center

Clearmind Medicine Enrolls First Patient in Study of Potential Alcohol Abuse Treatment

MT Newswires Live

Psychedelic: Clearmind completes clinical site initiations for AUD trial

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

BRIEF-Clearmind Medicine Completes The Initiation Of Its Alcohol Use Disorder Phase I/IIA Clinical Trial At All Current Clinical Sites

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

BRIEF-Clearmind Medicine Receives Notice Of Allowance For United States Patent Covering Binge Behavior

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CMND/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CMND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMND\",,,,,undefined,":{"symbol":"CMND","market":"US","secType":"STK","nameCN":"Clearmind Medicine, Inc.","latestPrice":1.03,"timestamp":1753473600000,"preClose":1.03,"halted":0,"volume":51116,"hourTrading":{"tag":"盘后","latestPrice":1.0201,"preClose":1.03,"latestTime":"19:41 EDT","volume":2415,"amount":2468.6101,"timestamp":1753486899931},"delay":0,"floatShares":4643565,"shares":5134786,"eps":-1.126594,"marketStatus":"Market Closed","change":0,"latestTime":"07-25 16:00:00 EDT","open":1.03,"high":1.08,"low":1.0166,"amount":52706.7401432,"amplitude":0.061553,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.126594,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753689600000},"marketStatusCode":7,"adr":0,"listingDate":1668142800000,"exchange":"NASDAQ","adjPreClose":1.03,"preHourTrading":{"tag":"盘前","latestPrice":1.0212,"preClose":1.03,"latestTime":"08:20 EDT","volume":893,"amount":904.7310731,"timestamp":1753446048069},"postHourTrading":{"tag":"盘后","latestPrice":1.0201,"preClose":1.03,"latestTime":"19:41 EDT","volume":2415,"amount":2468.6101,"timestamp":1753486899931},"volumeRatio":0.0508019801799114},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMND\",,,,,undefined,":{"symbol":"CMND","floatShares":4643565,"roa":"-52.23%","roe":"-139.17%","lyrEps":-1.694985,"volumeRatio":0.0508019801799114,"shares":5134786,"dividePrice":0,"high":1.08,"amplitude":0.061553,"preClose":1.03,"low":1.0166,"week52Low":0.8,"pbRate":"2.30","week52High":2.18,"institutionHeld":0,"latestPrice":1.03,"eps":-1.126594,"divideRate":0,"volume":51116,"delay":0,"ttmEps":-1.126594,"open":1.03,"prevYearClose":1.38,"prevWeekClose":1,"prevMonthClose":0.9,"prevQuarterClose":0.9,"fiveDayClose":1,"twentyDayClose":0.8816,"sixtyDayClose":1.03},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CMND\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553178940","title":"Psychedelic: Clearmind completes site initiation for CMND-100 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2553178940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553178940?lang=en_us&edition=fundamental","pubTime":"2025-07-24 22:50","pubTimestamp":1753368615,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a site initiation, a notice of al...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psychedelic-clearmind-completes-site-initiation-for-cmnd-100-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psychedelic-clearmind-completes-site-initiation-for-cmnd-100-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMND","BK4007"],"gpt_icon":0},{"id":"2553243550","title":"Clearmind Medicine completes initiation at TASMC for Phase I/IIa trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2553243550","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553243550?lang=en_us&edition=fundamental","pubTime":"2025-07-23 21:00","pubTimestamp":1753275630,"startTime":"0","endTime":"0","summary":"Clearmind Medicine (CMND) announced the completion of site initiation at Tel Aviv Sourasky Medical Center for its Phase I/IIa clinical trial evalua...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-completes-initiation-at-tasmc-for-phase-i-iia-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-completes-initiation-at-tasmc-for-phase-i-iia-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMND","BK4007"],"gpt_icon":0},{"id":"2553257243","title":"Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2553257243","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553257243?lang=en_us&edition=fundamental","pubTime":"2025-07-23 20:55","pubTimestamp":1753275300,"startTime":"0","endTime":"0","summary":"Vancouver, Canada, July  23, 2025  (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the \"Company\"), a clinical-stage biotech company focused on discovery and de","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/23/3120245/0/en/Clearmind-Medicine-Completes-Initiation-of-Leading-Israeli-Clinical-Site-for-Phase-I-IIa-Trial-of-CMND-100-in-Alcohol-Use-Disorder.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"gpt_icon":0},{"id":"2551626071","title":"Clearmind Medicine Inc. Expands Clinical Trial for CMND-100 in Alcohol Use Disorder with New Site at Johns Hopkins University","url":"https://stock-news.laohu8.com/highlight/detail?id=2551626071","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551626071?lang=en_us&edition=fundamental","pubTime":"2025-07-15 20:07","pubTimestamp":1752581264,"startTime":"0","endTime":"0","summary":"Clearmind Medicine Inc. Expands Clinical Trial for CMND-100 in Alcohol Use Disorder with New Site at Johns Hopkins University. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 15, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nNDL9r8qXm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"gpt_icon":0},{"id":"2548845873","title":"Clearmind Medicine Gets Approval for Alcohol Use Disorder Clinical Trial in Israel","url":"https://stock-news.laohu8.com/highlight/detail?id=2548845873","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548845873?lang=en_us&edition=fundamental","pubTime":"2025-07-03 21:24","pubTimestamp":1751549048,"startTime":"0","endTime":"0","summary":"Clearmind Medicine  said Thursday its ongoing phase 1/2a clinical trial assessing oral drug candidate CMND-100 in alcohol use disorder has received institutional review board approval from Tel Aviv Sourasky Medical Center in Israel.The approval will allow patient enrollment at the medical center before the start of the first-in-human trial at the site, the company said.The company's shares were up 31% in recent premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","CMND"],"gpt_icon":0},{"id":"2548216802","title":"Clearmind Medicine announces IRB approval for Phase 1/2a trial for AUD","url":"https://stock-news.laohu8.com/highlight/detail?id=2548216802","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548216802?lang=en_us&edition=fundamental","pubTime":"2025-07-03 20:50","pubTimestamp":1751547009,"startTime":"0","endTime":"0","summary":"Clearmind Medicine (CMND) has received Institutional Review Board approval from Tel Aviv Sourasky Medical Center in Tel Aviv, Israel, for its ongoi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-announces-irb-approval-for-phase-1-2a-trial-for-aud-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-announces-irb-approval-for-phase-1-2a-trial-for-aud-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CMND"],"gpt_icon":0},{"id":"2548019126","title":"Clearmind Medicine Inc. Doses First Participant in Groundbreaking Clinical Trial for Alcohol Use Disorder Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2548019126","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548019126?lang=en_us&edition=fundamental","pubTime":"2025-07-01 00:16","pubTimestamp":1751300213,"startTime":"0","endTime":"0","summary":"Clearmind Medicine Inc. has announced the initiation of a Phase I/IIa clinical trial for its proprietary drug candidate, CMND-100, aimed at treating Alcohol Use Disorder . The trial marks a significant step as the first participant has been dosed under controlled clinical settings. This multinational, multicenter study, conducted at prominent institutions such as Yale School of Medicine and Johns Hopkins University, seeks to establish the safety and optimal dosing of CMND-100. Additionally, it will explore early signals of efficacy, including reductions in alcohol consumption and cravings. The results of this trial have not yet been presented, as the study is ongoing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine In","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL35mdXT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"gpt_icon":0},{"id":"2547201394","title":"Clearmind Medicine announces first participant ever dosed with CMND-100","url":"https://stock-news.laohu8.com/highlight/detail?id=2547201394","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547201394?lang=en_us&edition=fundamental","pubTime":"2025-06-30 22:56","pubTimestamp":1751295362,"startTime":"0","endTime":"0","summary":"Clearmind Medicine (CMND) announced a historic milestone: the first participant has been dosed with CMND-100, its proprietary MEAI-based oral drug ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-announces-first-participant-ever-dosed-with-cmnd-100-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-announces-first-participant-ever-dosed-with-cmnd-100-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CMND"],"gpt_icon":0},{"id":"2546497377","title":"Clearmind Adds New Site to Trial for Experimental Alcohol Use Disorder Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2546497377","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546497377?lang=en_us&edition=fundamental","pubTime":"2025-06-27 21:34","pubTimestamp":1751031279,"startTime":"0","endTime":"0","summary":"Clearmind Medicine  said Friday it has added Hadassah-University Medical Center in Jerusalem as a new site for its ongoing clinical trial for its experimental alcohol use disorder treatment.The study is testing CMND-100, an experimental oral treatment developed to help people with alcohol use disorder. Researchers will also observe whether the drug helps reduce alcohol cravings and drinking habits, the company said.The new site will be led by Prof. Yossi Karko and will join other trial partners, including Yale, Johns Hopkins, Tel Aviv Sourasky Medical Center and IMCA.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CMND","BK4007"],"gpt_icon":0},{"id":"2546675749","title":"Clearmind Medicine expands global clinical trial targeting AUD market","url":"https://stock-news.laohu8.com/highlight/detail?id=2546675749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546675749?lang=en_us&edition=fundamental","pubTime":"2025-06-27 21:10","pubTimestamp":1751029817,"startTime":"0","endTime":"0","summary":"Clearmind Medicine (CMND) announced the addition of Hadassah-University Medical Center, Jerusalem, Israel, as a new clinical site for its ongoing P...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-expands-global-clinical-trial-targeting-aud-market-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-expands-global-clinical-trial-targeting-aud-market-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMND","BK4007"],"gpt_icon":0},{"id":"2546212721","title":"BRIEF-Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2546212721","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546212721?lang=en_us&edition=fundamental","pubTime":"2025-06-25 19:50","pubTimestamp":1750852248,"startTime":"0","endTime":"0","summary":"BRIEF-Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism TreatmentJune 25 (Reuters) - Clearmind Medicine Inc CMND.O:CLEARMIND MEDICINE ENROLLS FIRST PATIENT IN ITS CLINICAL ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nTUA9P0GMN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"gpt_icon":0},{"id":"2545150419","title":"Clearmind Medicine Expands Alcohol Use Disorder Clinical Trial with Addition of Tel Aviv Sourasky Medical Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2545150419","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545150419?lang=en_us&edition=fundamental","pubTime":"2025-06-23 19:57","pubTimestamp":1750679848,"startTime":"0","endTime":"0","summary":"Clearmind Medicine Inc., a clinical-stage biotech company, has announced the expansion of its ongoing Phase I/IIa clinical trial for the treatment of Alcohol Use Disorder  with the inclusion of Tel Aviv Sourasky Medical Center in Israel. The trial is evaluating CMND-100, a proprietary MEAI-based oral drug candidate. The enrollment of the first patient was completed earlier this month. The study at Tel Aviv Sourasky Medical Center will be led by Dr. David Zeltser. This expansion includes other prestigious institutions such as Yale School of Medicine and Johns Hopkins University School of Medicine. The trial aims to evaluate the safety, tolerability, and pharmacokinetic profile of CMND-100, while exploring its potential to reduce alcohol cravings and consumption in patients with AUD. Results from the trial have not yet been presented.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nNDL3dC0PD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"gpt_icon":0},{"id":"2541027724","title":"Clearmind Medicine Enrolls First Patient in Study of Potential Alcohol Abuse Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2541027724","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541027724?lang=en_us&edition=fundamental","pubTime":"2025-06-05 20:00","pubTimestamp":1749124856,"startTime":"0","endTime":"0","summary":"Clearmind Medicine  said it has enrolled the first patient for its phase 1/2a clinical trial of CMND-100, an oral drug candidate aimed at treating alcohol use disorder.The trial is aimed at assessing the safety, tolerability, and pharmacokinetic effects of CMND-100 in potentially reducing alcohol cravings and consumption, the clinical-stage company said.Shares of the company were up 6% in recent premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CMND","BK4007"],"gpt_icon":0},{"id":"2530215933","title":"Psychedelic: Clearmind completes clinical site initiations for AUD trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2530215933","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530215933?lang=en_us&edition=fundamental","pubTime":"2025-04-25 23:30","pubTimestamp":1745595026,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on site initiations, dosing completion and clinical site partnerships.Discover outperforming stocks and invest smarter with Top Smart Score Stocks.Filter, analyze, and streamline your search for investment opportunities using  Tipranks' Stock Screener.“AUD remains one of the most urgent and underserved public health challenges globally,” said Dr. Adi Zuloff-Shani, CEO. “With millions affected and current treatments often falling short, the study initiation for our FDA-approved CMND-100 trial marks a critical step toward potentially transforming the treatment landscape for alcoholism. We are honored to collaborate with world renowned institutions such as Yale and Johns Hopkins as we advance our mission to potentially provide safe, effective, and innovative solutions for individuals those suffering from alcoholism.”“Completing dosing of all participants in Part A of our 005 tria","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","DRUG","BK4168","KTTA","OPTHF","CMND","MYCOF","ENTBF","GHRS","ALID","PSYGF","SILO","BETRF","MDXXF","BK4547","SNPX","IXHL","CYBN","NUMIF","FLHLF","BK4202","MIRA","RVVTF","ATAI","PBM","AGNPF","BK4139","ENVB","SPRC","MNMD","BK4539","QNTM","NRXP","RLMD","SEEL","PHRRF","CMPS"],"gpt_icon":0},{"id":"2530184089","title":"SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2530184089","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530184089?lang=en_us&edition=fundamental","pubTime":"2025-04-25 19:59","pubTimestamp":1745582340,"startTime":"0","endTime":"0","summary":"TEL AVIV, Israel, April 25, 2025  -- SciSparc Ltd.  , a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced today that its collaboration with Clearmind Medicine Inc.  has led to the filing of a new international patent application for a proprietary treatment targeting anorexia, bulimia and other eating disorders.Eating disorders are serious mental health conditions that negatively impact an individual’s health, emotions, and ability to perform daily functions. Eating disorders are among the top ten leading causes of disability among young women and have one of the highest mortality rates compared to other mental disorders. According to recent studies, up to 70 million people globally are affected by eating disorders, with significant increases observed among children and adolescents. Global eating disorder prevalence increased from 3.4% to 7.8% between 2000 and 2018.Common shares of Clearmi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scisparc-clearmind-collaboration-leads-filing-115900685.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SPRC","CMND","BK4007"],"gpt_icon":0},{"id":"2530847021","title":"Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2530847021","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530847021?lang=en_us&edition=fundamental","pubTime":"2025-04-25 19:55","pubTimestamp":1745582100,"startTime":"0","endTime":"0","summary":"Vancouver, Canada, April 25, 2025  -- Clearmind Medicine Inc. ,  , a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the filing of a new international patent application for a proprietary treatment targeting anorexia, bulimia and other eating disorders.Eating disorders are serious mental health conditions that negatively impact an individual’s health, emotions, and ability to perform daily functions. Eating disorders are among the top ten leading causes of disability among young women and have one of the highest mortality rates compared to other mental disorders. According to recent studies, up to 70 million people globally are affected by eating disorders, with significant increases observed among children and adolescents. Global eating disorder prevalence increased from 3.4% to 7.8% between 2000 and 2018.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/clearmind-medicine-files-international-patent-115500327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CMND","BK4007"],"gpt_icon":0},{"id":"2529500545","title":"BRIEF-Clearmind Medicine Completes The Initiation Of Its Alcohol Use Disorder Phase I/IIA Clinical Trial At All Current Clinical Sites","url":"https://stock-news.laohu8.com/highlight/detail?id=2529500545","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529500545?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:37","pubTimestamp":1745411835,"startTime":"0","endTime":"0","summary":"BRIEF-Clearmind Medicine Completes The Initiation Of Its Alcohol Use Disorder Phase I/IIA Clinical Trial At All Current Clinical SitesApril 23 (Reuters) - Clearmind Medicine Inc CMND.O:CLEARMIND MEDIC","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nTUA17MKZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"gpt_icon":0},{"id":"2529030637","title":"Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites","url":"https://stock-news.laohu8.com/highlight/detail?id=2529030637","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529030637?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:25","pubTimestamp":1745411100,"startTime":"0","endTime":"0","summary":"The Company is now preparing for the enrollment of the first patient to receive Clearmind’s innovative treatment as part of the trial. Vancouver, Canada, April 23, 2025  -- Clearmind Medicine Inc. ,  , a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the initiation of its U.S. clinical trial site at the Yale School of Medicine’s Department of Psychiatry. With this initiation, the Company has now activated all planned sites for its clinical trial for its Phase I/IIa clinical trial in Alcohol Use Disorder  and can begin patient enrollment .Clearmind has completed all necessary preparations for the clinical trial, including obtaining Investigational New Drug  approval from the U.S. Food and Drug Administration  to start the Phase I/IIa clinical trial, Institutional Review Board  approvals from each clinical site, launch of its Electronic Data Capture  system to supp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/clearmind-medicine-completes-initiation-alcohol-122500446.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","CMND","EDC"],"gpt_icon":0},{"id":"2529801200","title":"Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts","url":"https://stock-news.laohu8.com/highlight/detail?id=2529801200","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529801200?lang=en_us&edition=fundamental","pubTime":"2025-04-21 21:15","pubTimestamp":1745241300,"startTime":"0","endTime":"0","summary":"Vancouver, Canada, April 21, 2025  -- Clearmind Medicine Inc. ,  , a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, is pleased to announce its upcoming live webinar titled \"Gazing Through the Crystal Ball.\" The event is scheduled for May 21, 2025, at 12:00 PM ET  and will feature a distinguished panel of experts discussing the evolving landscape of psychedelic science and business in the context of changing FDA policies and political climates.Rick Doblin, PhD – Founder and President of the Multidisciplinary Association for Psychedelic Studies . A trailblazer in psychedelic-assisted therapy, Dr. Doblin has dedicated his career to establishing safe, legal, and ethical uses of psychedelics through rigorous scientific research.Robin Carhart-Harris, PhD – Ralph Metzner Distinguished Professor of Neurology and Psychiatry at the University of California, San Francisco . Dr. Carhart-Har","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/clearmind-medicine-host-live-webinar-131500592.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","BK4007","HST","BK4585","BK4023","BK4588","MAPS","CMND","BK4218"],"gpt_icon":0},{"id":"2528371412","title":"BRIEF-Clearmind Medicine Receives Notice Of Allowance For United States Patent Covering Binge Behavior","url":"https://stock-news.laohu8.com/highlight/detail?id=2528371412","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528371412?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:44","pubTimestamp":1744893896,"startTime":"0","endTime":"0","summary":"BRIEF-Clearmind Medicine Receives Notice Of Allowance For United States Patent Covering Binge BehaviorApril 17 (Reuters) - Clearmind Medicine Inc CMND.O:CLEARMIND MEDICINE RECEIVES NOTICE OF ALLOWANCE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QU2OZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CMND\",params:#limit:5,,,undefined,":[{"market":"US","date":"2023-11-28","symbol":"CMND","defaultRemindTime":1701181800000,"type":"split","dateTimestamp":1701147600000,"forFactor":30,"toFactor":1,"ratio":30}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CMND\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CMND\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CMND\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CMND","date":"2025-07-25","current":-1.094042,"percent":0.541157,"low":-85.590719,"twenty":-18.243042,"median":-1.202815,"eighty":-0.550857,"high":-0.132425,"avg":-10.539309,"sd":19.336572,"marketCap":5288829},"quantilePoints":[{"date":"2020-07-31","current":-26.688751,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2655543.86},{"date":"2020-08-07","current":-26.688751,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2659296.56},{"date":"2020-08-14","current":-26.688751,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2683453.93},{"date":"2020-08-21","current":-26.688751,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2695636.65},{"date":"2020-08-28","current":-26.688751,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2713715.75},{"date":"2020-09-04","current":-26.688751,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2710530.81},{"date":"2020-09-11","current":-26.688751,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2698172.45},{"date":"2020-09-18","current":-26.688751,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2700364.44},{"date":"2020-09-25","current":-19.430851,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2652137.89},{"date":"2020-10-02","current":-19.430851,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2672966.88},{"date":"2020-10-09","current":-19.430851,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2708177.93},{"date":"2020-10-16","current":-19.430851,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2697619.9},{"date":"2020-10-23","current":-19.430851,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2705582.14},{"date":"2020-10-30","current":-19.430851,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2672826.27},{"date":"2020-11-06","current":-19.430851,"twenty":-61.834695,"median":-9.227851,"eighty":-5.327909,"marketCap":2729585.8},{"date":"2020-11-13","current":-19.430851,"twenty":-58.731697,"median":-9.227851,"eighty":-5.327909,"marketCap":2702313.58},{"date":"2020-11-20","current":-19.430851,"twenty":-49.917404,"median":-9.227851,"eighty":-5.327909,"marketCap":2722231.75},{"date":"2020-11-27","current":-19.430851,"twenty":-43.261737,"median":-9.227851,"eighty":-5.327909,"marketCap":2739910.48},{"date":"2020-12-04","current":-19.430851,"twenty":-41.597849,"median":-9.227851,"eighty":-5.327909,"marketCap":2777635.21},{"date":"2020-12-11","current":-19.430851,"twenty":-41.597849,"median":-9.227851,"eighty":-5.327909,"marketCap":2786514.1},{"date":"2020-12-18","current":-19.430851,"twenty":-41.597849,"median":-9.227851,"eighty":-5.327909,"marketCap":2782611.72},{"date":"2020-12-24","current":-19.430851,"twenty":-41.597849,"median":-9.227851,"eighty":-5.327909,"marketCap":2773130.45},{"date":"2020-12-31","current":-19.430851,"twenty":-41.597849,"median":-9.227851,"eighty":-5.327909,"marketCap":2791259.61},{"date":"2021-01-08","current":-19.430851,"twenty":-41.597849,"median":-9.227851,"eighty":-5.327909,"marketCap":2797670.85},{"date":"2021-01-15","current":-19.430851,"twenty":-41.597849,"median":-9.227851,"eighty":-5.327909,"marketCap":2792684.23},{"date":"2021-01-22","current":-19.430851,"twenty":-41.597849,"median":-9.227851,"eighty":-5.327909,"marketCap":2794856.82},{"date":"2021-01-29","current":-19.430851,"twenty":-41.597849,"median":-12.187757,"eighty":-5.327909,"marketCap":2782481.11},{"date":"2021-02-05","current":-19.430851,"twenty":-41.597849,"median":-15.147663,"eighty":-5.327909,"marketCap":2783787.82},{"date":"2021-02-12","current":-19.430851,"twenty":-41.597849,"median":-15.147663,"eighty":-5.327909,"marketCap":2799961.42},{"date":"2021-02-19","current":-19.430851,"twenty":-39.933931,"median":-15.147663,"eighty":-5.327909,"marketCap":2822403.07},{"date":"2021-02-26","current":-19.430851,"twenty":-37.438053,"median":-15.147663,"eighty":-5.327909,"marketCap":2800424.4},{"date":"2021-03-05","current":-8.613576,"twenty":-37.438053,"median":-15.147663,"eighty":-5.327909,"marketCap":2802476.56},{"date":"2021-03-12","current":-8.613576,"twenty":-37.438053,"median":-15.147663,"eighty":-5.327909,"marketCap":2848351.83},{"date":"2021-03-19","current":-8.613576,"twenty":-37.438053,"median":-15.147663,"eighty":-5.327909,"marketCap":2843228.53},{"date":"2021-03-26","current":-8.613576,"twenty":-37.438053,"median":-9.227851,"eighty":-5.327909,"marketCap":2828395.91},{"date":"2021-04-01","current":-11.587771,"twenty":-37.438053,"median":-9.227851,"eighty":-5.327909,"marketCap":2829836.18},{"date":"2021-04-09","current":-11.587771,"twenty":-37.438053,"median":-11.587771,"eighty":-5.327909,"marketCap":2832089.53},{"date":"2021-04-16","current":-11.587771,"twenty":-37.438053,"median":-11.587771,"eighty":-5.327909,"marketCap":2845184.59},{"date":"2021-04-23","current":-17.615217,"twenty":-37.438053,"median":-11.587771,"eighty":-5.327909,"marketCap":4326958.35},{"date":"2021-04-30","current":-17.615217,"twenty":-37.438053,"median":-11.587771,"eighty":-5.327909,"marketCap":4388776.06},{"date":"2021-05-07","current":-17.615217,"twenty":-37.438053,"median":-13.367717,"eighty":-5.327909,"marketCap":4452312.37},{"date":"2021-05-14","current":-17.615217,"twenty":-37.438053,"median":-15.147663,"eighty":-5.327909,"marketCap":4466989.71},{"date":"2021-05-21","current":-17.615217,"twenty":-37.438053,"median":-15.147663,"eighty":-5.327909,"marketCap":4486524.55},{"date":"2021-05-28","current":-78.078262,"twenty":-37.438053,"median":-15.147663,"eighty":-5.327909,"marketCap":19823707.07},{"date":"2021-06-04","current":-75.221742,"twenty":-37.438053,"median":-15.147663,"eighty":-5.327909,"marketCap":19088186.32},{"date":"2021-06-11","current":-71.413047,"twenty":-37.438053,"median":-16.38144,"eighty":-5.327909,"marketCap":18026757.96},{"date":"2021-06-18","current":-69.508697,"twenty":-41.597849,"median":-17.615217,"eighty":-5.327909,"marketCap":17101728.27},{"date":"2021-06-25","current":-77.126088,"twenty":-41.597849,"median":-17.615217,"eighty":-5.327909,"marketCap":19258243.57},{"date":"2021-07-02","current":-77.809745,"twenty":-41.597849,"median":-17.615217,"eighty":-5.327909,"marketCap":27345681.85},{"date":"2021-07-09","current":-81.267955,"twenty":-45.757607,"median":-17.615217,"eighty":-5.327909,"marketCap":28278833.84},{"date":"2021-07-16","current":-82.132509,"twenty":-57.232721,"median":-17.615217,"eighty":-5.327909,"marketCap":28316450.35},{"date":"2021-07-23","current":-82.99706,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":28633395.33},{"date":"2021-07-30","current":-84.726165,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":29489162.42},{"date":"2021-08-06","current":-83.861681,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":28960917.86},{"date":"2021-08-13","current":-80.403466,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":27911893.15},{"date":"2021-08-20","current":-61.38329,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":20727360.57},{"date":"2021-08-27","current":-66.570612,"twenty":-61.834695,"median":-18.523034,"eighty":-5.327909,"marketCap":22871673.05},{"date":"2021-09-03","current":-77.809807,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":26985610.07},{"date":"2021-09-10","current":-70.893378,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24346632.12},{"date":"2021-09-17","current":-71.757932,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24430331.48},{"date":"2021-09-24","current":-73.487039,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":25125635.9},{"date":"2021-10-01","current":-18.935815,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24276713.03},{"date":"2021-10-08","current":-18.012117,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23471549.77},{"date":"2021-10-15","current":-18.012117,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23660527.38},{"date":"2021-10-22","current":-17.781192,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23366442.66},{"date":"2021-10-29","current":-16.626569,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":21791515.03},{"date":"2021-11-05","current":-17.319343,"twenty":-61.834695,"median":-18.935815,"eighty":-5.327909,"marketCap":22614497.39},{"date":"2021-11-12","current":-16.16472,"twenty":-61.834695,"median":-18.473966,"eighty":-5.327909,"marketCap":20907283.62},{"date":"2021-11-19","current":-15.933796,"twenty":-61.834695,"median":-18.243042,"eighty":-5.327909,"marketCap":20493935.46},{"date":"2021-11-26","current":-17.319343,"twenty":-61.834695,"median":-18.243042,"eighty":-5.327909,"marketCap":22007930.87},{"date":"2021-12-03","current":-16.16472,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":20516830.56},{"date":"2021-12-10","current":-15.933796,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":20363701.64},{"date":"2021-12-17","current":-14.548248,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":18448575.82},{"date":"2021-12-23","current":-13.393625,"twenty":-61.834695,"median":-17.781192,"eighty":-5.327909,"marketCap":16986524.41},{"date":"2021-12-31","current":-13.393625,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":17198471.74},{"date":"2022-01-07","current":-12.700852,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":16298591.95},{"date":"2022-01-14","current":-12.239002,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":15851627.15},{"date":"2022-01-21","current":-10.853455,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":14077636.85},{"date":"2022-01-28","current":-12.931776,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":16468260.15},{"date":"2022-02-04","current":-14.548248,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18518085.11},{"date":"2022-02-11","current":-14.317323,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18343985.21},{"date":"2022-02-18","current":-14.317323,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18253458.39},{"date":"2022-02-25","current":-13.393625,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":17082383.51},{"date":"2022-03-04","current":-4.943147,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":14402278.55},{"date":"2022-03-11","current":-4.741385,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":13870054.34},{"date":"2022-03-18","current":-4.489184,"twenty":-61.834695,"median":-17.582743,"eighty":-5.327909,"marketCap":13226105.9},{"date":"2022-03-25","current":-2.663476,"twenty":-61.834695,"median":-17.550268,"eighty":-5.327909,"marketCap":12172123.95},{"date":"2022-04-01","current":-2.696359,"twenty":-61.834695,"median":-17.319343,"eighty":-5.327909,"marketCap":12315499.88},{"date":"2022-04-08","current":-3.090948,"twenty":-61.834695,"median":-17.319343,"eighty":-5.327909,"marketCap":14024131.41},{"date":"2022-04-14","current":-2.433299,"twenty":-61.834695,"median":-17.088418,"eighty":-5.327909,"marketCap":11016821.23},{"date":"2022-04-22","current":-2.30177,"twenty":-61.834695,"median":-16.857494,"eighty":-5.327909,"marketCap":10351738.45},{"date":"2022-04-29","current":-2.564829,"twenty":-61.834695,"median":-16.857494,"eighty":-5.327909,"marketCap":11431112.19},{"date":"2022-05-06","current":-2.531947,"twenty":-61.834695,"median":-16.511107,"eighty":-5.327909,"marketCap":11240443.79},{"date":"2022-05-13","current":-2.433299,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10747956.2},{"date":"2022-05-20","current":-2.466182,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10972362.04},{"date":"2022-05-27","current":-2.334652,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10462796.86},{"date":"2022-06-03","current":-2.400417,"twenty":-61.834695,"median":-15.933796,"eighty":-5.327909,"marketCap":10896966.45},{"date":"2022-06-10","current":-2.30177,"twenty":-61.834695,"median":-15.702871,"eighty":-5.327909,"marketCap":10273199.15},{"date":"2022-06-17","current":-2.400417,"twenty":-61.834695,"median":-15.471947,"eighty":-5.327909,"marketCap":10503138.41},{"date":"2022-06-24","current":-2.367534,"twenty":-61.744414,"median":-15.471947,"eighty":-5.327909,"marketCap":10469452.66},{"date":"2022-07-01","current":-1.560974,"twenty":-60.553176,"median":-15.147663,"eighty":-5.327909,"marketCap":10729626.02},{"date":"2022-07-08","current":-1.560974,"twenty":-57.232721,"median":-15.147663,"eighty":-5.327909,"marketCap":10710469.08},{"date":"2022-07-15","current":-1.605574,"twenty":-57.232721,"median":-15.147663,"eighty":-5.327909,"marketCap":10950633.46},{"date":"2022-07-22","current":-1.516375,"twenty":-57.130437,"median":-15.147663,"eighty":-5.327909,"marketCap":10468944.81},{"date":"2022-07-29","current":-1.427176,"twenty":-56.195971,"median":-15.147663,"eighty":-5.327909,"marketCap":9885259.74},{"date":"2022-08-05","current":-1.471776,"twenty":-55.226088,"median":-14.779173,"eighty":-5.327909,"marketCap":10092669.27},{"date":"2022-08-12","current":-1.427176,"twenty":-54.0772,"median":-14.548248,"eighty":-5.327909,"marketCap":9901792.86},{"date":"2022-08-19","current":-1.427176,"twenty":-43.677709,"median":-14.317323,"eighty":-5.327909,"marketCap":9745576.64},{"date":"2022-08-26","current":-1.382577,"twenty":-41.597849,"median":-14.317323,"eighty":-5.327909,"marketCap":9442770.76},{"date":"2022-09-02","current":-1.271079,"twenty":-41.597849,"median":-14.086399,"eighty":-5.327909,"marketCap":8615042.98},{"date":"2022-09-09","current":-1.427176,"twenty":-41.597849,"median":-14.086399,"eighty":-5.135307,"marketCap":9711214.67},{"date":"2022-09-16","current":-1.360278,"twenty":-41.597849,"median":-13.855475,"eighty":-5.135307,"marketCap":9096403.07},{"date":"2022-09-23","current":-1.248779,"twenty":-41.597849,"median":-13.62455,"eighty":-5.135307,"marketCap":8172150.47},{"date":"2022-09-30","current":-0.929266,"twenty":-41.597849,"median":-13.393625,"eighty":-5.135307,"marketCap":6512507.37},{"date":"2022-10-07","current":-1.087585,"twenty":-41.597849,"median":-13.393625,"eighty":-5.074202,"marketCap":7646662.48},{"date":"2022-10-14","current":-1.080702,"twenty":-41.597849,"median":-13.393625,"eighty":-5.074202,"marketCap":7496705.29},{"date":"2022-10-21","current":-1.049293,"twenty":-41.597849,"median":-13.278163,"eighty":-5.074202,"marketCap":7357917.44},{"date":"2022-10-28","current":-1.165881,"twenty":-41.597849,"median":-13.162701,"eighty":-5.074202,"marketCap":8234273.61},{"date":"2022-11-04","current":-1.08907,"twenty":-41.597849,"median":-13.162701,"eighty":-5.074202,"marketCap":7753472.39},{"date":"2022-11-11","current":-1.082212,"twenty":-38.270012,"median":-12.931776,"eighty":-5.074202,"marketCap":7833552.75},{"date":"2022-11-18","current":-1.935818,"twenty":-37.438053,"median":-12.700852,"eighty":-5.074202,"marketCap":13927482.09},{"date":"2022-11-25","current":-1.650458,"twenty":-37.438053,"median":-12.585389,"eighty":-5.074202,"marketCap":11873272.72},{"date":"2022-12-02","current":-1.27255,"twenty":-37.438053,"median":-12.008078,"eighty":-5.074202,"marketCap":9091614.07},{"date":"2022-12-09","current":-1.079739,"twenty":-37.438053,"median":-11.682462,"eighty":-4.943147,"marketCap":7625598.02},{"date":"2022-12-16","current":-1.40109,"twenty":-37.438053,"median":-11.587771,"eighty":-4.791826,"marketCap":9845331.19},{"date":"2022-12-23","current":-1.375382,"twenty":-37.438053,"median":-11.587771,"eighty":-4.741294,"marketCap":9740512.57},{"date":"2022-12-30","current":-1.141438,"twenty":-37.438053,"median":-11.587771,"eighty":-4.741294,"marketCap":8114893.38},{"date":"2023-01-06","current":-1.118301,"twenty":-37.438053,"median":-11.587771,"eighty":-4.539624,"marketCap":7989125.08},{"date":"2023-01-13","current":-1.62475,"twenty":-37.438053,"median":-11.587771,"eighty":-4.186477,"marketCap":11656520.47},{"date":"2023-01-20","current":-1.568192,"twenty":-37.438053,"median":-10.853455,"eighty":-4.136102,"marketCap":11253776.1},{"date":"2023-01-27","current":-1.33682,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9661985.46},{"date":"2023-02-03","current":-1.332642,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9371651.68},{"date":"2023-02-10","current":-1.393097,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9812413.93},{"date":"2023-02-17","current":-1.272187,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":8867258.2},{"date":"2023-02-24","current":-1.240431,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":8572078.87},{"date":"2023-03-03","current":-1.10085,"twenty":-37.438053,"median":-9.227851,"eighty":-3.551938,"marketCap":7606207.65},{"date":"2023-03-10","current":-1.198293,"twenty":-37.438053,"median":-9.227851,"eighty":-3.45974,"marketCap":8185550.86},{"date":"2023-03-17","current":-1.120516,"twenty":-37.438053,"median":-9.227851,"eighty":-2.755547,"marketCap":7980631.72},{"date":"2023-03-24","current":-0.916786,"twenty":-37.438053,"median":-9.227851,"eighty":-2.696359,"marketCap":6519731.67},{"date":"2023-03-31","current":-0.417647,"twenty":-37.438053,"median":-9.227851,"eighty":-2.624017,"marketCap":3018701.27},{"date":"2023-04-06","current":-0.132425,"twenty":-37.438053,"median":-9.227851,"eighty":-2.584558,"marketCap":960449.73},{"date":"2023-04-14","current":-0.500779,"twenty":-37.438053,"median":-9.227851,"eighty":-2.531947,"marketCap":3666478.25},{"date":"2023-04-21","current":-0.622397,"twenty":-37.438053,"median":-9.227851,"eighty":-2.499064,"marketCap":4520895.91},{"date":"2023-04-28","current":-0.579473,"twenty":-37.438053,"median":-9.227851,"eighty":-2.453029,"marketCap":4166925.01},{"date":"2023-05-05","current":-0.550857,"twenty":-37.438053,"median":-9.227851,"eighty":-2.433299,"marketCap":3966371.91},{"date":"2023-05-12","current":-0.558011,"twenty":-37.438053,"median":-9.227851,"eighty":-2.433299,"marketCap":4046484.45},{"date":"2023-05-19","current":-0.572319,"twenty":-37.438053,"median":-9.227851,"eighty":-2.400417,"marketCap":4145445.66},{"date":"2023-05-26","current":-0.58694,"twenty":-37.438053,"median":-9.227851,"eighty":-2.367534,"marketCap":4210059.56},{"date":"2023-06-02","current":-0.550709,"twenty":-37.438053,"median":-9.227851,"eighty":-2.367534,"marketCap":3999105.96},{"date":"2023-06-09","current":-0.514478,"twenty":-34.942175,"median":-9.227851,"eighty":-2.321499,"marketCap":3767591.98},{"date":"2023-06-16","current":-0.531091,"twenty":-33.278257,"median":-9.227851,"eighty":-2.30177,"marketCap":3748293.76},{"date":"2023-06-23","current":-0.458354,"twenty":-33.278257,"median":-9.227851,"eighty":-2.28204,"marketCap":3234938.84},{"date":"2023-06-30","current":-0.478478,"twenty":-30.295333,"median":-9.227851,"eighty":-2.043589,"marketCap":3376966.22},{"date":"2023-07-07","current":-0.436578,"twenty":-26.688751,"median":-9.227851,"eighty":-1.802136,"marketCap":3081249.21},{"date":"2023-07-14","current":-0.436972,"twenty":-26.688751,"median":-8.613576,"eighty":-1.651163,"marketCap":3084034.14},{"date":"2023-07-21","current":-0.43717,"twenty":-26.688751,"median":-8.613576,"eighty":-1.562418,"marketCap":3085429.18},{"date":"2023-07-28","current":-0.458608,"twenty":-26.688751,"median":-8.613576,"eighty":-1.560974,"marketCap":3236727.75},{"date":"2023-08-04","current":-0.483799,"twenty":-26.688751,"median":-8.613576,"eighty":-1.558522,"marketCap":3414522.56},{"date":"2023-08-11","current":-0.383836,"twenty":-26.688751,"median":-6.222948,"eighty":-1.516375,"marketCap":2709008.42},{"date":"2023-08-18","current":-0.372906,"twenty":-26.688751,"median":-5.926622,"eighty":-1.471776,"marketCap":2631871.39},{"date":"2023-08-25","current":-0.39406,"twenty":-26.688751,"median":-5.926622,"eighty":-1.471776,"marketCap":2781166.24},{"date":"2023-09-01","current":-0.447028,"twenty":-26.688751,"median":-5.926622,"eighty":-1.427176,"marketCap":3155002.59},{"date":"2023-09-08","current":-0.442472,"twenty":-19.813329,"median":-5.926622,"eighty":-1.427176,"marketCap":3122844.46},{"date":"2023-09-15","current":-0.187109,"twenty":-19.430851,"median":-5.926622,"eighty":-1.427176,"marketCap":1320569.3},{"date":"2023-09-22","current":-0.388305,"twenty":-19.430851,"median":-5.926622,"eighty":-1.427176,"marketCap":2475737.22},{"date":"2023-09-29","current":-0.315336,"twenty":-19.430851,"median":-5.926622,"eighty":-1.415486,"marketCap":2010507.36},{"date":"2023-10-06","current":-0.365327,"twenty":-19.430851,"median":-5.926622,"eighty":-1.395726,"marketCap":2329231.67},{"date":"2023-10-13","current":-0.367265,"twenty":-19.430851,"median":-5.926622,"eighty":-1.382577,"marketCap":2341589.46},{"date":"2023-10-20","current":-0.334674,"twenty":-19.430851,"median":-5.926622,"eighty":-1.368527,"marketCap":2133796.18},{"date":"2023-10-27","current":-0.290523,"twenty":-19.430851,"median":-5.926622,"eighty":-1.366813,"marketCap":1852300.65},{"date":"2023-11-03","current":-0.316281,"twenty":-19.430851,"median":-5.926622,"eighty":-1.360278,"marketCap":2016523.46},{"date":"2023-11-10","current":-0.325261,"twenty":-19.430851,"median":-5.390754,"eighty":-1.337978,"marketCap":2073784.82},{"date":"2023-11-17","current":-0.300361,"twenty":-19.430851,"median":-5.330934,"eighty":-1.337515,"marketCap":1915028.46},{"date":"2023-11-24","current":-0.302508,"twenty":-19.430851,"median":-5.327909,"eighty":-1.335149,"marketCap":1928712.73},{"date":"2023-12-01","current":-0.350938,"twenty":-19.430851,"median":-5.327909,"eighty":-1.296306,"marketCap":2237493.37},{"date":"2023-12-08","current":-0.980569,"twenty":-19.430851,"median":-5.327909,"eighty":-1.274244,"marketCap":6251864.25},{"date":"2023-12-15","current":-0.736628,"twenty":-19.430851,"median":-5.327909,"eighty":-1.271301,"marketCap":4696557.28},{"date":"2023-12-22","current":-0.812759,"twenty":-19.430851,"median":-5.327909,"eighty":-1.259672,"marketCap":5181946.56},{"date":"2023-12-29","current":-0.682126,"twenty":-19.430851,"median":-5.327909,"eighty":-1.237797,"marketCap":4349066.88},{"date":"2024-01-05","current":-0.630384,"twenty":-19.430851,"median":-5.327909,"eighty":-1.211461,"marketCap":4019166.25},{"date":"2024-01-12","current":-0.436686,"twenty":-19.430851,"median":-5.327909,"eighty":-1.179486,"marketCap":2784200.42},{"date":"2024-01-19","current":-0.561866,"twenty":-19.430851,"median":-5.327909,"eighty":-1.15795,"marketCap":3582314.16},{"date":"2024-01-26","current":-0.716167,"twenty":-19.430851,"median":-5.327909,"eighty":-1.132962,"marketCap":4566100.74},{"date":"2024-02-02","current":-0.652747,"twenty":-19.430851,"median":-5.327909,"eighty":-1.116775,"marketCap":5627224.65},{"date":"2024-02-09","current":-0.504935,"twenty":-19.430851,"median":-5.327909,"eighty":-1.1005,"marketCap":4352964.23},{"date":"2024-02-16","current":-0.519849,"twenty":-19.430851,"median":-5.327909,"eighty":-1.096168,"marketCap":4481532.37},{"date":"2024-02-23","current":-0.672729,"twenty":-18.473966,"median":-5.327909,"eighty":-1.087585,"marketCap":5799482.19},{"date":"2024-03-01","current":-0.54179,"twenty":-18.473966,"median":-5.327909,"eighty":-1.08191,"marketCap":4670679.77},{"date":"2024-03-08","current":-0.505134,"twenty":-18.473966,"median":-5.327909,"eighty":-1.079739,"marketCap":4354677.58},{"date":"2024-03-15","current":-0.435211,"twenty":-18.473966,"median":-5.327909,"eighty":-1.064778,"marketCap":3751886.19},{"date":"2024-03-22","current":-0.499967,"twenty":-18.473966,"median":-5.327909,"eighty":-1.046318,"marketCap":4044318},{"date":"2024-03-28","current":-0.471743,"twenty":-18.473966,"median":-5.327909,"eighty":-0.975962,"marketCap":3816009},{"date":"2024-04-05","current":-0.463679,"twenty":-18.473966,"median":-5.327909,"eighty":-0.890377,"marketCap":3750779},{"date":"2024-04-12","current":-0.516095,"twenty":-18.473966,"median":-5.327909,"eighty":-0.810049,"marketCap":4174780},{"date":"2024-04-19","current":-0.475009,"twenty":-18.473966,"median":-5.327909,"eighty":-0.7392,"marketCap":3842428},{"date":"2024-04-26","current":-0.483839,"twenty":-18.473966,"median":-5.327909,"eighty":-0.711567,"marketCap":3913856},{"date":"2024-05-03","current":-0.471784,"twenty":-18.473966,"median":-5.327909,"eighty":-0.652729,"marketCap":3816336},{"date":"2024-05-10","current":-0.604799,"twenty":-18.473966,"median":-5.327909,"eighty":-0.644215,"marketCap":4892320},{"date":"2024-05-17","current":-0.520127,"twenty":-18.473966,"median":-5.327909,"eighty":-0.61393,"marketCap":4207395},{"date":"2024-05-24","current":-0.453599,"twenty":-18.473966,"median":-5.327909,"eighty":-0.600881,"marketCap":3669240},{"date":"2024-05-31","current":-0.459647,"twenty":-18.473966,"median":-5.327909,"eighty":-0.594105,"marketCap":3718163},{"date":"2024-06-07","current":-0.420053,"twenty":-18.473966,"median":-5.109555,"eighty":-0.586092,"marketCap":3397879},{"date":"2024-06-14","current":-0.435455,"twenty":-18.473966,"median":-5.074202,"eighty":-0.577013,"marketCap":3522470},{"date":"2024-06-21","current":-0.612279,"twenty":-18.473966,"median":-5.074202,"eighty":-0.572319,"marketCap":4237588},{"date":"2024-06-28","current":-0.64098,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":4436225},{"date":"2024-07-05","current":-0.727082,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5032136},{"date":"2024-07-12","current":-0.770133,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5330091},{"date":"2024-07-15","current":-0.813184,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5628047},{"date":"2024-08-02","current":-0.717515,"twenty":-19.331844,"median":-5.074202,"eighty":-0.562464,"marketCap":4965924},{"date":"2024-08-09","current":-0.569229,"twenty":-19.331844,"median":-5.074202,"eighty":-0.562464,"marketCap":3939633},{"date":"2024-08-16","current":-0.545311,"twenty":-19.331844,"median":-5.074202,"eighty":-0.558549,"marketCap":3774102},{"date":"2024-08-23","current":-0.660114,"twenty":-19.331844,"median":-5.008674,"eighty":-0.558011,"marketCap":4568650},{"date":"2024-08-30","current":-0.631413,"twenty":-19.331844,"median":-4.791826,"eighty":-0.558011,"marketCap":4370013},{"date":"2024-09-06","current":-0.617063,"twenty":-19.331844,"median":-4.539624,"eighty":-0.558011,"marketCap":4270694},{"date":"2024-09-13","current":-0.631413,"twenty":-19.331844,"median":-4.09773,"eighty":-0.558011,"marketCap":4370013},{"date":"2024-09-20","current":-0.506022,"twenty":-19.331844,"median":-4.059359,"eighty":-0.552636,"marketCap":4270694},{"date":"2024-09-27","current":-0.595973,"twenty":-19.331844,"median":-4.059359,"eighty":-0.550947,"marketCap":5029855},{"date":"2024-10-04","current":-0.595973,"twenty":-19.331844,"median":-4.059359,"eighty":-0.550947,"marketCap":5029855},{"date":"2024-10-11","current":-0.653648,"twenty":-19.331844,"median":-4.04729,"eighty":-0.550947,"marketCap":5516615},{"date":"2024-10-18","current":-0.634423,"twenty":-19.331844,"median":-2.811447,"eighty":-0.550947,"marketCap":5354362},{"date":"2024-10-25","current":-0.74016,"twenty":-19.331844,"median":-2.696359,"eighty":-0.550947,"marketCap":6246755},{"date":"2024-10-31","current":-0.70171,"twenty":-19.331844,"median":-2.614152,"eighty":-0.550947,"marketCap":5922249},{"date":"2024-11-08","current":-0.672873,"twenty":-19.430851,"median":-2.531947,"eighty":-0.550857,"marketCap":5678869},{"date":"2024-11-15","current":-0.706517,"twenty":-19.430851,"median":-2.499064,"eighty":-0.550857,"marketCap":5962812},{"date":"2024-11-22","current":-0.644036,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5435488},{"date":"2024-11-29","current":-0.624811,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5273235},{"date":"2024-12-06","current":-0.639229,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5394925},{"date":"2024-12-13","current":-0.70171,"twenty":-19.430851,"median":-2.400417,"eighty":-0.550857,"marketCap":5922249},{"date":"2024-12-20","current":-0.571942,"twenty":-19.430851,"median":-2.367534,"eighty":-0.550857,"marketCap":4827038},{"date":"2024-12-27","current":-0.749773,"twenty":-19.430851,"median":-2.367534,"eighty":-0.550857,"marketCap":6327882},{"date":"2025-01-03","current":-0.696904,"twenty":-19.430851,"median":-2.30177,"eighty":-0.550857,"marketCap":5881685},{"date":"2025-01-10","current":-0.692098,"twenty":-19.430851,"median":-2.30177,"eighty":-0.550857,"marketCap":5841122},{"date":"2025-01-17","current":-0.730548,"twenty":-19.430851,"median":-2.153798,"eighty":-0.550857,"marketCap":6165629},{"date":"2025-01-24","current":-1.150202,"twenty":-19.430851,"median":-1.874119,"eighty":-0.550857,"marketCap":6043939},{"date":"2025-01-31","current":-1.042129,"twenty":-19.430851,"median":-1.662503,"eighty":-0.550857,"marketCap":5476052},{"date":"2025-02-07","current":-1.160721,"twenty":-19.430851,"median":-1.581046,"eighty":-0.550857,"marketCap":6099215},{"date":"2025-02-14","current":-1.13637,"twenty":-19.430851,"median":-1.560974,"eighty":-0.550857,"marketCap":5971260},{"date":"2025-02-21","current":-1.038967,"twenty":-19.430851,"median":-1.560974,"eighty":-0.550857,"marketCap":5459438},{"date":"2025-02-28","current":-0.990265,"twenty":-19.430851,"median":-1.541199,"eighty":-0.550857,"marketCap":5203526},{"date":"2025-03-07","current":-0.900979,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":4734356},{"date":"2025-03-14","current":-0.917213,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":4819660},{"date":"2025-03-21","current":-1.211596,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":6007699},{"date":"2025-03-28","current":-1.08733,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":5391525},{"date":"2025-04-04","current":-1.066619,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":5288829},{"date":"2025-04-11","current":-0.966947,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":4794606},{"date":"2025-04-17","current":-1.004486,"twenty":-19.430851,"median":-1.424416,"eighty":-0.550857,"marketCap":4980742},{"date":"2025-04-25","current":-1.014841,"twenty":-19.430851,"median":-1.40109,"eighty":-0.550857,"marketCap":5032090},{"date":"2025-05-02","current":-1.056263,"twenty":-19.430851,"median":-1.382577,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-05-09","current":-1.011735,"twenty":-19.430851,"median":-1.375382,"eighty":-0.550857,"marketCap":5016685},{"date":"2025-05-16","current":-1.004486,"twenty":-19.430851,"median":-1.366813,"eighty":-0.550857,"marketCap":4980742},{"date":"2025-05-23","current":-1.035552,"twenty":-19.430851,"median":-1.360278,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-05-30","current":-1.001379,"twenty":-19.430851,"median":-1.337978,"eighty":-0.550857,"marketCap":4965338},{"date":"2025-06-06","current":-0.973316,"twenty":-19.430851,"median":-1.337978,"eighty":-0.550857,"marketCap":4826185},{"date":"2025-06-13","current":-0.909542,"twenty":-19.430851,"median":-1.332642,"eighty":-0.550857,"marketCap":4396917},{"date":"2025-06-20","current":-0.913472,"twenty":-19.430851,"median":-1.295818,"eighty":-0.550857,"marketCap":4415915},{"date":"2025-06-27","current":-0.936415,"twenty":-19.430851,"median":-1.273609,"eighty":-0.550857,"marketCap":4526827},{"date":"2025-07-03","current":-1.168394,"twenty":-19.430851,"median":-1.261673,"eighty":-0.550857,"marketCap":5648264},{"date":"2025-07-11","current":-1.040933,"twenty":-19.430851,"median":-1.240431,"eighty":-0.550857,"marketCap":5032090},{"date":"2025-07-18","current":-1.072798,"twenty":-18.473966,"median":-1.211461,"eighty":-0.550857,"marketCap":5186133},{"date":"2025-07-25","current":-1.094042,"twenty":-18.243042,"median":-1.202815,"eighty":-0.550857,"marketCap":5288829}],"updateTime":1753538819342}}}